151 related articles for article (PubMed ID: 16671337)
21. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
Patel TV; Williams GH; Fisher ND
J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
[TBL] [Abstract][Full Text] [Related]
22. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
[TBL] [Abstract][Full Text] [Related]
23. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
Hannila-Handelberg T; Kontula KK; Paukku K; Lehtonen JY; Virtamo J; Tikkanen I; Hiltunen TP
J Hypertens; 2010 Apr; 28(4):771-9. PubMed ID: 20027122
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
Akram J; Sheikh UE; Mahmood M; Donnelly R
Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
[TBL] [Abstract][Full Text] [Related]
25. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients.
van den Born BJ; van Montfrans GA; Uitterlinden AG; Zwinderman AH; Koopmans RP
J Hypertens; 2007 Nov; 25(11):2227-33. PubMed ID: 17921816
[TBL] [Abstract][Full Text] [Related]
26. Effect of angiotensin converting enzyme inhibitors on 1.25-(OH)2 D levels of hypertensive patients. Relationship with ACE polymorphisms.
Pérez-Castrillón JL; Justo I; Sanz A; De Luis D; Dueñas A
Horm Metab Res; 2006 Dec; 38(12):812-6. PubMed ID: 17163356
[TBL] [Abstract][Full Text] [Related]
27. Effect of angiotensin II type I receptor A1166C polymorphism on benazepril action in hypertensive patients: a family-based association test study.
Zhang N; Cui H; Yang L
Arch Pharm Res; 2012 Oct; 35(10):1817-22. PubMed ID: 23139134
[TBL] [Abstract][Full Text] [Related]
28. [Association of polymorphisms in the angiotensin system genes with obstructive sleep apnea-hypopnea syndrome].
Zhang LQ; Yao WZ; He QY; Wang YZ; Ren B; Lin YP
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):507-10. PubMed ID: 15387996
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
30. Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors.
Chen YY; Liu D; Zhang P; Zhong JC; Zhang CJ; Wu SL; Zhang YQ; Liu GZ; He M; Jin LJ; Yu HM
J Hum Hypertens; 2016 Dec; 30(12):766-771. PubMed ID: 27121444
[TBL] [Abstract][Full Text] [Related]
31. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension.
Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS
Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532
[TBL] [Abstract][Full Text] [Related]
32. [Meta-analysis on the association of AGT M235T polymorphism and essential hypertension in Chinese population].
Chen P; Jiang YF; Cheng K
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):711-4. PubMed ID: 14521795
[TBL] [Abstract][Full Text] [Related]
33. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic parameters and heart rate variability during a tilt test in relation to gene polymorphism of renin-angiotensin and serotonin system.
Mitro P; Mudráková K; Micková H; Dudás J; Kirsch P; Valocik G
Pacing Clin Electrophysiol; 2008 Dec; 31(12):1571-80. PubMed ID: 19067809
[TBL] [Abstract][Full Text] [Related]
35. [Association of angiotensinogen gene polymorphism with hypertension in type 2 diabetic patients].
Xue YM; Guan MP; Liu SQ; Zhang Q; Zhou L
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1191-3. PubMed ID: 14625185
[TBL] [Abstract][Full Text] [Related]
36. The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with the level of decrease on diastolic blood pressure in essential hypertension patients treated by angiotensin-converting enzyme inhibitor.
Jiang S; Hsu YH; Xu X; Xing H; Chen C; Niu T; Zhang Y; Peng S; Xu X
Thromb Res; 2004; 113(6):361-9. PubMed ID: 15226090
[TBL] [Abstract][Full Text] [Related]
37. [The relationship between polymorphism of angiotensinogen gene and essential hypertension].
Liu J; Zhang Y; Yu S
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):407-9. PubMed ID: 11860821
[TBL] [Abstract][Full Text] [Related]
38. Role of two angiotensinogen polymorphisms in blood pressure variation.
Robinson M; Williams SM
J Hum Hypertens; 2004 Dec; 18(12):865-9. PubMed ID: 15343353
[TBL] [Abstract][Full Text] [Related]
39. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
[TBL] [Abstract][Full Text] [Related]
40. Association of ACE genotype and predominantly diastolic hypertension: a preliminary study.
Jiménez PM; Conde C; Casanegra A; Romero C; Tabares AH; Orías M
J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):42-4. PubMed ID: 17487825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
